Kelley Drye Represents Columbia Laboratories in Sale of Healthcare Products Portfolio
August 18, 2004
As reported in the New Jersey Law Journal, Kelley Drye represented Columbia Laboratories, Inc. in the sale of its portfolio of over-the-counter (OTC) women’s healthcare products to Lil’ Drug Store Products, Inc. The transaction included an asset purchase agreement, a substantial supply agreement, a professional promotion agreement and patent licenses.

The Lil’ Drug Store purchased global rights for two of Columbia’s products and foreign marketing rights for an additional product. The companies executed a five year supply agreement and a two-and-a-half year agreement for Columbia’s sales force to continue to promote these OTC products, together with Columbia's remaining prescription products portfolio, to OB/GYNs in the United States. Columbia is entitled to payments as well as ongoing revenues from the manufacture and sale of products to Lil’ Drug Store, promotional fees under a professional services agreement and royalties on product sales.